Inventor

SERHAN CHARLES N

US90 patents

⚠️ This page may combine multiple inventors who share the name “SERHAN CHARLES N”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SERHAN CHARLES N

BRIGHAM & WOMENS HOSPITAL

Lipoxin compounds

Aspirin-triggered lipid mediators

Lipoxin compounds and their use in treating cell proliferative disorders

Lipoxin compounds and their use in treating cell proliferative disorders

Lipoxin compounds and their use in treating cell proliferative disorders

Lipoxin compounds and their use in treating cell proliferative disorders

Lipoxin compounds and their use in treating cell proliferative disorders

Lipoxin compounds and their use in treating cell proliferative disorders

Lipoxin compounds and their use in treating cell proliferative disorders

Lipoxin compounds

Lipoxin compounds and their use in treating cell proliferative disorders

Lipoxin compounds and their use in treating cell proliferative disorders

Prevention of neutrophil recruitment

Inhibition of TNFα-initiated neutrophil response

Inhibition of TNFα-initiated neutrophil response

Regulation of phospholipase D activity

Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs

Approach to anti-microbial host defense with molecular shields with EPA and DHA analogs

Modulation of inflammation related to columnar epithelia

Aspirin-triggered lipid mediators

Aspirin-triggered lipid mediators

Analogues of lipid mediators derived from omega-3 PUFAs and methods of use

Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis

Lipoxin analogs as novel inhibitors of angiogenesis

Lipoxin analogs as novel inhibitors of angiogenesis

Resolvins: Biotemplates for novel therapeutic interventions

Use of docasatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthma

Prevention of neutrophil recruitment

Modulation of inflammation related to Columnar epithelia

Screening methods for presqualene diphosphate analogs

Polyisoprenyl phosphate stable analogs for regulation of neutrophil responses

Prevention of neutrophil recruitment

Prevention of neutrophil recruitment

SERHAN CHARLES N

Aspirin-triggered lipid mediators

14-hydroxy-docosahexaenoic acid compounds

Lipoxin compounds and their use in treating cell proliferative disorders

Docosahexaenoyl ethanolamides

Use of docosatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthma

Anti-inflammatory actions of neuroprotectin D1/protectin D1 and it&#39;s natural stereoisomers

Method for treating airway hyper-responsiveness with lipoxin analogs

Inhibition of TNF-α-initiated neutrophil response

BRINGHAM AND WOMEN S HOSPITAL

Lipoxin compounds and their use in treating cell proliferative disorders

(unassigned)

Modulation of inflammation related to columnar epithelia

BRIGHAM AND WOMAN S HOSPITAL I

Aspirin-triggered lipid mediators

BRIGHAM AND WOMEN S HOPSITAL

Inhibition of TNF-(α)-initiated neutrophil response

BRIGHAM WOMEN S HOSPITAL INC

Modulation of inflammation related to columnar epithelia

BRIGHAM & WOMENS HOSPITAL INC

14-hydroxy-docosahexaenoic acid compounds

VAN DYKE THOMAS E

Lipoxin analogs and methods for the treatment of periodontal disease

UNIV CALIFORNIA

Compounds and methods for modulating vascular injury

RESOLVYX PHARMACUTICALS INC

Analogues of lipid mediators derived from ω-3 PUFAs and methods of use

Anti-inflammatory actions of neuroprotectin D1/protectin D1 and it's natural stereoisomers